In a compelling joint appeal, 12 leading public health organizations across five European Union member states are urgently calling upon prospective Members of the European Parliament (MEPs) to prioritize and ensure access to affordable medicines for all EU citizens. The timing of this call is critical, with the upcoming European Parliament elections slated for June 6 to 9, 2024. These organizations are urging both re-elected and new MEPs to champion measures that will counter the rising challenges associated with the accessibility and affordability of medical products within the EU. The crux of the issue lies in the escalating costs of new medicines, rendering them financially out of reach for many patients—either due to high out-of-pocket expenses or the burden placed on national health budgets when reimbursed. The current landscape favors pharmaceutical companies, granting them monopoly rights and allowing exorbitant pricing practices even for medicines developed with public fu...
welcome to the world of the man with the largest following and the man people fight for.